Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;26(6):791-6.
doi: 10.3346/jkms.2011.26.6.791. Epub 2011 May 18.

Seroepidemiology of hepatitis A in Korea: changes over the past 30 years

Hyunju Lee  1 , Hye Kyung Cho, Jong-Hyun Kim, Kyung-Hyo Kim
Affiliations

Seroepidemiology of hepatitis A in Korea: changes over the past 30 years

Hyunju Lee et al. J Korean Med Sci. 2011 Jun.

Abstract

This study aimed to assess the immune status of the Korean population against hepatitis A virus (HAV). Residual serum samples from 2008 to 2010 were collected from diagnostic laboratories and a total of 1,872 samples were analyzed. Anti-HAV seroprevalence was 57.3% in subjects aged 1-4 yr, 69.8% at 5-9 yr and decreased to 38.8% at 10-14 yr, 13.0% at 15-19 yr, and 11.7% at 20-29 yr. Seroprevalence increased with increasing age: 52.2% at 30-39 yr, 83.2% at 40-49 yr, 81.4% at 50-59 yr, 93.2% at 60-69 yr, and 95.1% at 70-79 yr. The most susceptible age group consisted of subjects aged 10-29 yr, especially those aged 20-29 yr. This pattern is markedly different from that in the past 3 decades, where the most susceptible group had consisted of children aged less than 10 yr and almost all subjects aged more than 20 yr had developed anti-HAV antibodies. Because of improvements in hygiene and introduction of hepatitis A vaccine, the age demographic of the susceptible population has shifted. These data are important for creating new prevention measures, including vaccination policies, to prevent and control outbreaks of hepatitis A in Korea.

Keywords: Hepatitis A; Seroepidemiologic Studies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Age specific seroprevalence against hepatitis A in Korea.
Fig. 2
Fig. 2
Changes of seroprevalence against hepatitis A in Korea from 1979 to 2010 (data from reference no. 8, 9, 15). (A) Changes over different periods (10-yr intervals) according to age group, (B) Changes among age groups over the past 30 yr.
See this image and copyright information in PMC

References

    1. Bell BP, Feinstone SM. Hepatitis A Vaccine. In: Plotkin SA, Oreinstein WA, editors. Vaccines. 4th ed. Philadelphia, PA: Saunders; 2004. pp. 269–297.
    1. Kim JH. Recent epidemiological status and vaccination of hepatitis A in Korea. J Korean Med Assoc. 2008;51:110–118.
    1. Center for Disease Control and Prevention (CDC) Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 1999;48:1–37. - PubMed
    1. Lee BC, Lee DB. Clinical observation of type A hepatitis in children. J Korean Pediatr Soc. 1979;22:213–222.
    1. Kim NJ, Sung JK, Lee SW, Lee KT, Lee SM, Kim SH, Lee BS, Kim JH, Yu JH, Lee HY. An outbreak of hepatitis A in Taejeon city. Korean J Gastroenterol. 1999;34:205–212.

Substances